These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 16367941)

  • 1. Expression of OX40 (CD134) on CD4+ T-cells from patients with myasthenia gravis.
    Xiaoyan Z; Pirskanen R; Malmstrom V; Lefvert AK
    Clin Exp Immunol; 2006 Jan; 143(1):110-6. PubMed ID: 16367941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD134 expression on CD4+ T cells is associated with nephritis and disease activity in patients with systemic lupus erythematosus.
    Patschan S; Dolff S; Kribben A; Dürig J; Patschan D; Wilde B; Specker C; Philipp T; Witzke O
    Clin Exp Immunol; 2006 Aug; 145(2):235-42. PubMed ID: 16879242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation-associated phenotype of CD3 T cells in acute graft-versus-host disease.
    Paz Morante M; Briones J; Canto E; Sabzevari H; Martino R; Sierra J; Rodriguez-Sanchez JL; Vidal S
    Clin Exp Immunol; 2006 Jul; 145(1):36-43. PubMed ID: 16792671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of T cell activation antigen CD134 (OX40) has no predictive value for the occurrence or response to therapy of acute graft-versus-host disease in partial T cell-depleted bone marrow transplantation.
    Gadisseur AP; Gratama JW; Lamers C; van Esser JW; Bolhuis RL; Cornelissen JJ
    Bone Marrow Transplant; 1999 May; 23(10):1013-7. PubMed ID: 10373067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD25 expression distinguishes functionally distinct alloreactive CD4 CD134 (OX40) T-cell subsets in acute graft-versus-host disease.
    Streeter PR; Zhang X; Tittle TV; Schön CN; Weinberg AD; Maziarz RT
    Biol Blood Marrow Transplant; 2004 May; 10(5):298-309. PubMed ID: 15111929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD4+CD25+ T-cell populations expressing CD134 and GITR are associated with disease activity in patients with Wegener's granulomatosis.
    Wilde B; Dolff S; Cai X; Specker C; Becker J; Tötsch M; Costabel U; Dürig J; Kribben A; Tervaert JW; Schmid KW; Witzke O
    Nephrol Dial Transplant; 2009 Jan; 24(1):161-71. PubMed ID: 18723571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of rat OX40 ligand by monoclonal antibody.
    Satake Y; Akiba H; Takeda K; Atsuta M; Yagita H; Okumura K
    Biochem Biophys Res Commun; 2000 Apr; 270(3):1041-8. PubMed ID: 10772947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High levels of costimulatory receptors OX40 and 4-1BB characterize CD4+CD28null T cells in patients with acute coronary syndrome.
    Dumitriu IE; Baruah P; Finlayson CJ; Loftus IM; Antunes RF; Lim P; Bunce N; Kaski JC
    Circ Res; 2012 Mar; 110(6):857-69. PubMed ID: 22282196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased OX40 and soluble OX40 ligands in children with Henoch-Schonlein purpura: association with renal involvement.
    Qin W; Hongya W; Yongjing C; Fang X; Yue M; Xuekun Z; Xiaozhong L; Xueguang Z
    Pediatr Allergy Immunol; 2011 Feb; 22(1 Pt 1):54-9. PubMed ID: 21143648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. OX40 (CD134) engagement drives differentiation of CD4+ T cells to effector cells.
    Huddleston CA; Weinberg AD; Parker DC
    Eur J Immunol; 2006 May; 36(5):1093-103. PubMed ID: 16541471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thiol levels in CD134-defined subsets of rat T lymphocytes: possible implications for HgCl2-induced immune dysregulation.
    Roos A; Claessen N; Schilder-Tol EJ; Chand MA; Weening JJ; Aten J
    Biochem Biophys Res Commun; 1997 Nov; 240(2):452-7. PubMed ID: 9388500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetic of regulatory CD25high and activated CD134+ (OX40) T lymphocytes during acute and chronic graft-versus-host disease after allogeneic bone marrow transplantation.
    Sanchez J; Casaño J; Alvarez MA; Roman-Gomez J; Martin C; Martinez F; Gomez P; Serrano J; Herrera C; Torres A
    Br J Haematol; 2004 Sep; 126(5):697-703. PubMed ID: 15327522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical implication of peripheral CD4+CD25+ regulatory T cells and Th17 cells in myasthenia gravis patients.
    Masuda M; Matsumoto M; Tanaka S; Nakajima K; Yamada N; Ido N; Ohtsuka T; Nishida M; Hirano T; Utsumi H
    J Neuroimmunol; 2010 Aug; 225(1-2):123-31. PubMed ID: 20472307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and costimulatory effects of the TNF receptor superfamily members CD134 (OX40) and CD137 (4-1BB), and their role in the generation of anti-tumor immune responses.
    Taraban VY; Rowley TF; O'Brien L; Chan HT; Haswell LE; Green MH; Tutt AL; Glennie MJ; Al-Shamkhani A
    Eur J Immunol; 2002 Dec; 32(12):3617-27. PubMed ID: 12516549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of CD4 T cell memory by OX40 (CD134).
    Salek-Ardakani S; Croft M
    Vaccine; 2006 Feb; 24(7):872-83. PubMed ID: 16176850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. OX40 (CD134) expression in sentinel lymph nodes correlates with prognostic features of primary melanomas.
    Sarff M; Edwards D; Dhungel B; Wegmann KW; Corless C; Weinberg AD; Vetto JT
    Am J Surg; 2008 May; 195(5):621-5; discussion 625. PubMed ID: 18374895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD4+ T cells and cytokines in the pathogenesis of acquired myasthenia gravis.
    Conti-Fine BM; Milani M; Wang W
    Ann N Y Acad Sci; 2008; 1132():193-209. PubMed ID: 18567869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibodies to OX-40 (CD134) can identify and eliminate autoreactive T cells: implications for human autoimmune disease.
    Weinberg AD
    Mol Med Today; 1998 Feb; 4(2):76-83. PubMed ID: 9547794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Requirements for the functional expression of OX40 ligand on human activated CD4+ and CD8+ T cells.
    Kondo K; Okuma K; Tanaka R; Zhang LF; Kodama A; Takahashi Y; Yamamoto N; Ansari AA; Tanaka Y
    Hum Immunol; 2007 Jul; 68(7):563-71. PubMed ID: 17584577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Normalization of elevated CD4-/CD8- (double-negative) T cells after thymectomy parallels clinical remission in myasthenia gravis associated with thymic hyperplasia but not thymoma.
    Reinhardt C; Melms A
    Ann Neurol; 2000 Oct; 48(4):603-8. PubMed ID: 11026443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.